Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zefeng Xu

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Nature Communications|June 4, 2026
Opto-optical edge defect mitigation in solution-processed WSe<sub>2</sub> thin films for high-efficiency optical modulationJianan Li, Zefeng Xu, Yuan Chen, et al.
Haematologica|August 25, 2022
<i>ASXL1</i> mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasmsZhongxun Shi, Jinqin Liu, Yingying Zhao, et al.
Haematologica|January 6, 2022
Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single centerDan Liu, Zefeng Xu, Peihong Zhang, et al.
Haematologica|September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosisRui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Genes, Chromosomes & Cancer|October 24, 2017
Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromesBing Li, Jinqin Liu, Yujiao Jia, et al.
Leukemia|April 11, 2019
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpointsYunzhu Dong, Xinghui Zhao, Xiaomin Feng, et al.
Blood Cancer Journal|August 18, 2020
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centreHuijun Huang, Changlu Xu, Jie Gao, et al.
Cancer Discovery|August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic SyndromesYoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly Geyer, Robyn Scherber, Heidi Kosiorek, et al.
Leukemia Research|November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needsAllison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Nature Communications|June 4, 2026
Opto-optical edge defect mitigation in solution-processed WSe<sub>2</sub> thin films for high-efficiency optical modulationJianan Li, Zefeng Xu, Yuan Chen, et al.
Haematologica|August 25, 2022
<i>ASXL1</i> mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasmsZhongxun Shi, Jinqin Liu, Yingying Zhao, et al.
Haematologica|January 6, 2022
Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single centerDan Liu, Zefeng Xu, Peihong Zhang, et al.
Haematologica|September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosisRui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Genes, Chromosomes & Cancer|October 24, 2017
Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromesBing Li, Jinqin Liu, Yujiao Jia, et al.
Leukemia|April 11, 2019
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpointsYunzhu Dong, Xinghui Zhao, Xiaomin Feng, et al.
Blood Cancer Journal|August 18, 2020
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centreHuijun Huang, Changlu Xu, Jie Gao, et al.
Cancer Discovery|August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic SyndromesYoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly Geyer, Robyn Scherber, Heidi Kosiorek, et al.
Leukemia Research|November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needsAllison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.
Pageof 13